Cidara Therapeutics Inc (NASDAQ:CDTX)

Delayed Data
As of 3:58pm ET
 +0.0705 / +9.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Cidara Therapeutics Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +477.00% increase from the last price of 0.78.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cidara Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.52%
Growthannually 46.51%


Growthquarterly 46.61%
Growthannually 19.40%
Key to the earnings and sales forecast charts.